Published in Indian J Dermatol on November 10, 2010
Dermatoses due to Indian cultural practices. Indian J Dermatol (2015) 1.20
Chemical Leucoderma Induced by Ear-ring Stoppers Made of Polyvinyl Chloride. J Cutan Aesthet Surg (2012) 0.81
Chemical-Induced Vitiligo. Dermatol Clin (2017) 0.75
Keratoconjunctivitis caused by an unusual retained conjunctival foreign body: a frequently unrecognized entity. Indian J Ophthalmol (2014) 0.75
Mechanism of depigmentation by hydroquinone. J Invest Dermatol (1974) 1.62
On the etiology of contact/occupational vitiligo. Pigment Cell Res (2004) 1.55
Occupational vitiligo due to paratertiary butylphenol and homologues. Trans St Johns Hosp Dermatol Soc (1971) 1.22
Occupational vitiligo induced by p-tert-butylphenol, a systemic disease? Lancet (1977) 1.17
Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol (2008) 1.16
Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds. J Invest Dermatol (1968) 1.01
Detection of environmental depigmenting substances. Contact Dermatitis (1979) 1.00
The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol (2000) 0.93
Occupational depigmentation due to 4-tertiarybutyl catechol (TBC). J Occup Med (1970) 0.92
Contact depigmentation from free para-tertiary-butylphenol in bindi adhesive. Contact Dermatitis (1990) 0.88
The azo dye solvent yellow 3 produces depigmentation. Contact Dermatitis (2000) 0.86
Amulet string contact leukoderma and its differentiation from vitiligo. Indian J Dermatol Venereol Leprol (2007) 0.86
Contact depigmentation caused by an azo dye in alta. Contact Dermatitis (1998) 0.85
Hair dye depigmentation. Contact Dermatitis (1996) 0.85
Footwear depigmentation. Contact Dermatitis (1996) 0.85
Contact leukoderma associated with the use of hair colors. Cutis (1993) 0.84
Contact leukoderma due to 'Bindi' and footwear. Dermatologica (1985) 0.84
Contact depigmentation of the breast. Contact Dermatitis (1991) 0.83
Condom leukoderma. Indian J Dermatol Venereol Leprol (2006) 0.82
Persistent leukoderma after henna tattoo. Contact Dermatitis (2007) 0.82
Hair-dye-induced contact vitiligo treated by phototherapy. Contact Dermatitis (2007) 0.81
Perioral leukoderma simulating vitiligo from use of a toothpaste containing cinnamic aldehyde. Arch Dermatol (1980) 0.79
Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops. Indian J Ophthalmol (2008) 0.79
Occupational vitiligo. Contact Dermatitis (1988) 0.79
A simple spectroscopic technique proposed for scanning the depigmenting potential of azo dyes. Contact Dermatitis (2004) 0.78
Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds. J Invest Dermatol (1987) 0.78
Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol (2008) 2.13
Granuloma multiforme. Int J Dermatol (2004) 1.66
Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol (2002) 1.16
A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry (2003) 1.10
Topical corticosteroid use in children: adverse effects and how to minimize them. Indian J Dermatol Venereol Leprol (2010) 0.96
Patch testing experience with 1000 patients. Indian J Dermatol Venereol Leprol (2007) 0.96
Chronic but not resistant mania: a case report. Acta Psychiatr Scand (2004) 0.95
Hypomagnesemia in relation to digoxin intoxication in children. Am Heart J (1976) 0.86
Bulimia nervosa. Indian J Pediatr (2004) 0.85
A new grading system for oral pemphigus. Int J Dermatol (2003) 0.85
Short-term methotrexate therapy in psoriasis: a study of 197 patients. Int J Dermatol (2002) 0.80
Frequency of patch-test positivity in patients with psoriasis: a prospective controlled study. Acta Derm Venereol (2002) 0.80
Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol (2010) 0.79
A novelliposomal formulation of dithranol for psoriasis: preliminary results. J Dermatol (2002) 0.77
Oral lichen planus: an update. Drugs Today (Barc) (2002) 0.77
Dermatoses of pregnancy: role of circulating fetal cells? J Am Acad Dermatol (2002) 0.75
[Comment on "Wolf's isotopic response: herpes simplex appearing on scrofuloderma scar."]. Int J Dermatol (2005) 0.75
Aluminium contact sensitivity. Contact Dermatitis (1997) 0.75
Treatment of genital lichen sclerosus with topical calcipotriol. Int J STD AIDS (2005) 0.75
Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India. J Dermatol (2003) 0.75
Minoxidil vs finasteride in the treatment of men with androgenetic alopecia. Arch Dermatol (2003) 0.75
Excessive drowsiness with low-dose methotrexate. Int J Dermatol (2004) 0.75
Neurovascular antropylorus perineal transposition using inferior rectal nerve anastomosis for total anorectal reconstruction: preliminary report in humans. Tech Coloproctol (2013) 0.75
A young boy with lip swelling and wrinkled eyelids. Arch Dermatol (2003) 0.75
Naevus sebaceous papilliferum. Indian J Dermatol Venereol Leprol (2007) 0.75
Co-localization of epidermal nevi and psoriasis:are we closer to an explanation? Int J Dermatol (2005) 0.75
"A natural sweat test" in leprosy. Int J Lepr Other Mycobact Dis (2002) 0.75
Acropigmentation of Dohi in an Indian family. J Dermatol (2002) 0.75
Sudden irreversible worsening of myopia with isotretinoin treatment. Indian J Dermatol Venereol Leprol (2011) 0.75